A61K39/0008 - page 3 - CPC Classification Index

#601

20150283218

2015-10-08

Peptide conjugated particles

#602

20150273032

2015-10-01

Regulatory T cell epitope and hepatitis C virus homolog

#603

20150250871

2015-09-10

METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS

#604

20150250862

2015-09-10

Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis

#605

20150247847

2015-09-03

Diagnostic method for detecting an autoimmune disease

#606

20150239979

2015-08-27

Compositions and methods

#607

20150238583

2015-08-27

DNA vaccines encoding heat shock proteins

#608

20150231216

2015-08-20

Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif

#609

20150224146

2015-08-13

Cell populations having immunoregulatory activity, method for isolation and uses

#610

20150209446

2015-07-30

Methods and compositions for treating multiple sclerosis and related disorders

#611

20150209387

2015-07-30

Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes

#612

20150209293

2015-07-30

Peptide conjugated particles for the treatment of allergy

#613

20150202285

2015-07-23

Compositions and methods for modulating immune responses

#614

20150196636

2015-07-16

Immunoregulatory vaccine

#615

20150196597

2015-07-16

Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection

#616

20150192582

2015-07-09

CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs

#617

20150190489

2015-07-09

KIF20A epitope peptides for TH1 cells and vaccines containing the same

#618

20150190485

2015-07-09

Peptide conjugated particles

#619

20150174168

2015-06-25

Acellular pro-tolerogenic compositions and process for making same

#620

20150165007

2015-06-18

THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1

#621

20150165006

2015-06-18

Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen

#622

20150164948

2015-06-18

Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases

#623

20150150996

2015-06-04

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

#624

20150150956

2015-06-04

EPITOPE COMPOSITION

#625

20150140043

2015-05-21

IMMUNOMODULATORY METHODS USING NOTCH AGONISTS

#626

20150125536

2015-05-07

Methods and compositions for sustained immunotherapy

#627

20150125514

2015-05-07

BIOMARKER

#628

20150125421

2015-05-07

Cytokine-based fusion proteins for treatment of immune disorders

#629

20150104414

2015-04-16

Cytokines and neuroantigens for treatment of immune disorders

#630

20150098956

2015-04-09

Recombinant polypeptides comprising MHC class II α1 domains

#631

20150098953

2015-04-09

Methods of treating a patient having an autoimmune disorder by administering a soluble BCMA

#632

20150087806

2015-03-26

Glycopeptide and uses thereof

#633

20150086593

2015-03-26

Allergy inhibitor compositions and kits and methods of using the same

#634

20150086584

2015-03-26

MULTI-SPECIFIC BINDING AGENTS

#635

20150079131

2015-03-19

Prevention of inflammatory disorders in domestic non-human mammals

#636

20150079026

2015-03-19

Controlled release formulations for the induction and proliferation of blood cells

#637

20150071967

2015-03-12

Tolerisation-Inducing Composition

#638

20150064206

2015-03-05

COMPOSITIONS FOR TREATING UVEITIS

#639

20150056678

2015-02-26

Method of preparing apoptotic monocytes

#640

20150023909

2015-01-22

Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12

#641

20140370035

2014-12-18

Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

#642

20140363446

2014-12-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#643

20140356387

2014-12-04

METHOD FOR INDUCING IMMUNE TOLERANCE THROUGH TARGETTED GENE EXPRESSION

#644

20140356384

2014-12-04

Erythrocyte-binding therapeutics

#645

20140322266

2014-10-30

Induction of mucosal tolerance to antigens

#646

20140322230

2014-10-30

Induction of mucosal tolerance to antigens

#647

20140322161

2014-10-30

Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6

#648

20140302153

2014-10-09

Methods and treatment for allergies and inflammation associated with gastrointestinal diseases

#649

20140294982

2014-10-02

Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions

#650

20140286948

2014-09-25

Methods for treating scleroderma by administering a soluble CTLA4 molecule

#651

20140286871

2014-09-25

Method for inducing a tolerogenic immune response

#652

20140286858

2014-09-25

Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions

#653

20140255411

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#654

20140255389

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#655

20140248316

2014-09-04

HYBRID CELLS FOR TREATING CANCER PATIENTS

#656

20140242101

2014-08-28

PD-L1 based immunotherapy

#657

20140234423

2014-08-21

Programming of cells for tolerogenic therapies

#658

20140220015

2014-08-07

COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES

#659

20140220011

2014-08-07

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#660

20140212473

2014-07-31

Glycopeptide and uses thereof

#661

20140212445

2014-07-31

Use of modified cells for the treatment of multiple sclerosis

#662

20140199340

2014-07-17

Tolerogenic synthetic nanocarriers for inducing regulatory B cells

#663

20140199333

2014-07-17

Aquaporin-4 peptide compositions and methods of use thereof

#664

20140161832

2014-06-12

Methods of using myelin basic protein peptide compositions

#665

20140161831

2014-06-12

Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis

#666

20140154315

2014-06-05

Hydrophobic Preparations

#667

20140147455

2014-05-29

Antigen surrogates in autoimmune disease

#668

20140134196

2014-05-15

Vaccine and method for treatment of neurodegenerative diseases

#669

20140134103

2014-05-15

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

#670

20140127268

2014-05-08

Method for expanding monocytes

#671

20140072593

2014-03-13

Method for suppressing an immune response

#672

20140056848

2014-02-27

Method for the treatment of multiple sclerosis

#673

20140044641

2014-02-13

Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer

#674

20140036506

2014-02-06

Expandable liquid volume in an LED bulb

#675

20140023617

2014-01-23

Method for treating IFNalpha related conditions

#676

20140017218

2014-01-16

Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes

#677

20130336999

2013-12-19

PEPTIDE WITH REDUCED DIMER FORMATION

#678

20130330414

2013-12-12

Methods and compositions for treating inflammation

#679

20130330374

2013-12-12

Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus

#680

20130315904

2013-11-28

Combinations of modalities for the treatment of diabetes

#681

20130310273

2013-11-21

Methods and means for diagnosing vasculitis

#682

20130309229

2013-11-21

RECOMBINANT T CELL LIGANDS AND ANTIBODIES THAT BIND B CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#683

20130287729

2013-10-31

Antigen-specific, tolerance-inducing microparticles and uses thereof

#684

20130273089

2013-10-17

ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES

#685

20130259885

2013-10-03

Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination

#686

20130251744

2013-09-26

Virus like particle composition

#687

20130251671

2013-09-26

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

#688

20130243767

2013-09-19

Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies

#689

20130230518

2013-09-05

Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule

#690

20130216621

2013-08-22

BIFUNCTIONAL CONJUGATE COMPOSITIONS AND ASSOCIATED METHODS

#691

20130216591

2013-08-22

Composition and method for inducing antigen-specific tolerance using IgA

#692

20130216565

2013-08-22

Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein

#693

20130209498

2013-08-15

Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease

#694

20130195903

2013-08-01

COMPOSITIONS FOR USE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES AND ASTHMA

#695

20130195791

2013-08-01

Conjugates comprising an -oxime bond and associated methods

#696

20130190221

2013-07-25

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

#697

20130177593

2013-07-11

Personalized site-specific immunomodulation

#698

20130156798

2013-06-20

Peptide composition

#699

20130149332

2013-06-13

Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Obesity

#700

20130129771

2013-05-23

Regulatory immune cells with enhanced targeted cell death effect

#701

20130129742

2013-05-23

Human leukolectins and uses thereof

#702

20130089566

2013-04-11

VACCINE PREVENTING AND/OR TREATING AUTOIMMUNE DISEASES

#703

20130059009

2013-03-07

COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERS

#704

20130058978

2013-03-07

INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLS

#705

20130058977

2013-03-07

COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPES

#706

20130058976

2013-03-07

ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPY

#707

20130058975

2013-03-07

ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSES

#708

20130058974

2013-03-07

ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES

#709

20130058970

2013-03-07

INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINES

#710

20130058969

2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

#711

20130058964

2013-03-07

Methods for activating T cells and modulating an immune response

#712

20130058963

2013-03-07

INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLS

#713

20130058902

2013-03-07

DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODS

#714

20130058901

2013-03-07

TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE

#715

20130058894

2013-03-07

THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE

#716

20130052214

2013-02-28

IDENTIFICATION OF A PEPTIDE(S) THAT INDUCES AUTOIMMUNE ANTERIOR UVEITIS

#717

20130027941

2013-01-31

Expandable liquid volume in an LED bulb

#718

20130022634

2013-01-24

Mutant CTAI fusion protein for treatment of allergy and autoimmune disease

#719

20130017213

2013-01-17

Peptide analogues

#720

20130007926

2013-01-03

Administration of plant expressed oral tolerance agents

#721

20120321651

2012-12-20

Anti-IGE Vaccines

#722

20120321555

2012-12-20

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

#723

20120301510

2012-11-29

TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE

#724

20120301498

2012-11-29

CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS

#725

20120301492

2012-11-29

COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY

#726

20120294888

2012-11-22

Tolerogenic synthetic nanocarriers for allergy therapy

#727

20120294886

2012-11-22

PEPTIDE CONJUGATES FOR SUPPRESSING AN IMMUNE RESPONSE, METHODS OF MAKING AND USES THEREFOR

#728

20120294884

2012-11-22

METHODS OF BLOCKING TISSUE DESTRUCTION BY AUTOREACTIVE T CELLS

#729

20120276160

2012-11-01

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES

#730

20120276159

2012-11-01

Tolerogenic synthetic nanocarriers

#731

20120276158

2012-11-01

Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses

#732

20120276157

2012-11-01

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

#733

20120276156

2012-11-01

TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE

#734

20120276155

2012-11-01

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells

#735

20120276134

2012-11-01

Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells

#736

20120276133

2012-11-01

Tolerogenic synthetic nanocarriers for inducing regulatory B cells

#737

20120276127

2012-11-01

Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)

#738

20120276109

2012-11-01

Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins

#739

20120269838

2012-10-25

Method of vaccination for limiting articular inflammation in rheumatoid arthritis and multiple sclerosis by administering IL-23 peptides

#740

20120269836

2012-10-25

Vaccine

#741

20120269834

2012-10-25

IMMUNOGLOBULIN CLEAVAGE FRAGMENT VACCINE COMPOSITIONS

#742

20120263693

2012-10-18

Method for treating chronic lymphocytic leukemia (CC)

#743

20120258135

2012-10-11

Immunogenic anti-inflammatory compositions

#744

20120258094

2012-10-11

Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule

#745

20120219574

2012-08-30

Antigen surrogates in autoimmune disease

#746

20120213828

2012-08-23

Adenovirus vaccine vector and methods of use

#747

20120213808

2012-08-23

CARBONIC ANHYDRASE I SERVING AS NOVEL ANTIGEN TO BE USED FOR TREATMENT OF AUTOIMMUNE DISEASES

#748

20120207773

2012-08-16

MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE

#749

20120207745

2012-08-16

Composition to Induce Specific Immune Tolerance

#750

20120201027

2012-08-09

Expandable liquid volume in an LED bulb

#751

20120189624

2012-07-26

Detection of amyloid deposits using anti-amyloid antibodies

#752

20120178139

2012-07-12

Erythrocyte-binding therapeutics

#753

20120177597

2012-07-12

COMPOSITIONS AND METHODS OF ALTERATION OF AUTOIMMUNE DISEASES

#754

20120171233

2012-07-05

Peptide inhibitors for mediating stress responses

#755

20120171212

2012-07-05

Therapeutic compositions and methods for the prevention of autoimmune diseases

#756

20120164107

2012-06-28

Cyclic di-AMP induction of type I interferon

#757

20120148526

2012-06-14

STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF

#758

20120141537

2012-06-07

ENHANCING T CELL ACTIVATION USING ALTERED MHC-PEPTIDE LIGANDS

#759

20120141515

2012-06-07

Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE

#760

20120136338

2012-05-31

IMMUNOLOGIC COMPOUNDS FOR PREVENTION, PROTECTION, PROPHYLAXIS OR TREATMENT OF IMMUNOLOGICAL DISORDERS, INFECTIONS AND CANCER

#761

20120135431

2012-05-31

Type IV collagen-like immunoreactive peptide

#762

20120134997

2012-05-31

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#763

20120123099

2012-05-17

AUTOANTIBODY PRODUCTION INHIBITOR

#764

20120122207

2012-05-17

Method for expanding monocytes

#765

20120121620

2012-05-17

ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER

#766

20120121592

2012-05-17

Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells

#767

20120121539

2012-05-17

Programming of cells for tolerogenic therapies

#768

20120115161

2012-05-10

COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH

#769

20120114674

2012-05-10

Molecular Antigen Array

#770

20120114598

2012-05-10

IL-1alpha immunization induces autoantibodies protective against atherosclerosis

#771

20120107268

2012-05-03

Compositions and methods for modulating an immune response

#772

20120093934

2012-04-19

METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES

#773

20120082644

2012-04-05

CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS

#774

20120076831

2012-03-29

COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE

#775

20120076808

2012-03-29

COMBINED ANTIGEN AND DNA VACCINE FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES

#776

20120059358

2012-03-08

DNA vaccines encoding heat shock proteins

#777

20120052081

2012-03-01

Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma

#778

20120040377

2012-02-16

Recognition of CYP2E1 epitopes

#779

20120039989

2012-02-16

Erythrocyte-binding therapeutics

#780

20120039984

2012-02-16

GLYCOPEPTIDE AND USES THEREOF

#781

20120039926

2012-02-16

Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells

#782

20120039878

2012-02-16

Anti-amyloid antibodies

#783

20120034249

2012-02-09

Methods for treating progressive multifocal leukoencephalopathy (PML)

#784

20120034206

2012-02-09

BREAST CANCER ERADICATION PROGRAM

#785

20120033440

2012-02-09

Expandable liquid volume in an LED bulb

#786

20120028911

2012-02-02

Mucin derived polypeptides

#787

20120028258

2012-02-02

Receptor gene screening for detecting or diagnosing cancer

#788

20120014978

2012-01-19

Compositions with reduced dimer formation

#789

20110311536

2011-12-22

PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE

#790

20110311529

2011-12-22

Method for treating a rheumatic disease using a soluble TLA4 molecule

#791

20110305723

2011-12-15

Molecular Antigen Array

#792

20110300166

2011-12-08

Vaccine compositions compromising βs-crystallin for inducing immune responses against components of drusen

#793

20110300142

2011-12-08

USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS

#794

20110287048

2011-11-24

Antigen Specific Tregs and related compositions, methods and systems

#795

20110268767

2011-11-03

USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES

#796

20110268752

2011-11-03

Inducible regulatory T-cell generation for hematopoietic transplants

#797

20110243981

2011-10-06

Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)

#798

20110243935

2011-10-06

Compositions and Methods for Immunotherapy

#799

20110224408

2011-09-15

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

#800

20110223145

2011-09-15

IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME

#801

20110218328

2011-09-08

Chimeric, humanized, or human antibody 2A4

#802

20110212097

2011-09-01

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#803

20110206706

2011-08-25

Vaccine and method for treatment of neurodegenerative diseases

#804

20110206659

2011-08-25

METHODS AND TREATMENT FOR ALLERGIES AND INFLAMMATION ASSOCIATED WITH GASTROINTESTINAL DISEASES

#805

20110195080

2011-08-11

Methods for enhanced somatostatin immunogenicity in the treatment of obesity

#806

20110189178

2011-08-04

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

#807

20110182921

2011-07-28

REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF

#808

20110150878

2011-06-23

COMPOSITIONS AND METHODS FOR MANIPULATING LEVELS OF ANTIGEN-SPECIFIC ANTIBODIES IN A MAMMAL

#809

20110150845

2011-06-23

METHODS AND COMPOSITIONS FOR MODULATING IMMUNOLOGICAL TOLERANCE

#810

20110143995

2011-06-16

NOVEL ANTI-ALLERGIC AGENTS

#811

20110142866

2011-06-16

PEPTIDE ANALOGUES AND CONJUGATES THEREOF

#812

20110135678

2011-06-09

TOLERIZING AGENTS

#813

20110135624

2011-06-09

THERAPEUTIC COMPOSITION FOR AUTOIMMUNE CONDITIONS

#814

20110123561

2011-05-26

METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE

#815

20110123558

2011-05-26

Peptide with reduced dimer formation

#816

20110123557

2011-05-26

Anti-HMGA1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of HMGA1

#817

20110123540

2011-05-26

POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES

#818

20110110950

2011-05-12

Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BCMA

#819

20110097313

2011-04-28

Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells

#820

20110086800

2011-04-14

SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER

#821

20110081371

2011-04-07

Angiotensin peptide-carrier conjugates and uses thereof

#822

20110065187

2011-03-17

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#823

20110065186

2011-03-17

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#824

20110065180

2011-03-17

EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE

#825

20110059121

2011-03-10

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

#826

20110053843

2011-03-03

E-selectin compositions and use thereof for inducing E-selectin tolerance

#827

20110052535

2011-03-03

COMPOSITIONS FOR TREATING AN INFLAMMATORY AUTOIMMUNE CONDITION

#828

20110052529

2011-03-03

METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS

#829

20110052525

2011-03-03

Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid

#830

20110038844

2011-02-17

COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION

#831

20110038790

2011-02-17

Treatment and prophylaxis of amyloidosis

#832

20110034543

2011-02-10

DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus

#833

20110033479

2011-02-10

PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES

#834

20110033426

2011-02-10

Use of modified cells for the treatment of multiple sclerosis

#835

20110027301

2011-02-03

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#836

20110027222

2011-02-03

Vaccine for the Treatment of Osteoarthritis

#837

20110021747

2011-01-27

IgE antigenic peptides

#838

20110020309

2011-01-27

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#839

20110015370

2011-01-20

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#840

20110014206

2011-01-20

Screening method for predicting susceptibility to breast cancer

#841

20110008282

2011-01-13

IL-1alpha immunization induces autoantibodies protective against atherosclerosis

#842

20100330110

2010-12-30

THERAPEUTIC AND DIAGNOSTIC USES OF ANTIBODY SPECIFICITY PROFILES

#843

20100316673

2010-12-16

NANOEMULSION VACCINES

#844

20100310656

2010-12-09

Immunotherapy and prevention of autoimmune hepatitis

#845

20100310588

2010-12-09

REGULATORY T CELLS SUPPRESS AUTOIMMUNITY

#846

20100303866

2010-12-02

Immunogenic peptides and their use in immune disorders

#847

20100303842

2010-12-02

PEPTIDE ANALOGUES

#848

20100303825

2010-12-02

Anti-estrogen and immune modulator combinations for treating breast cancer

#849

20100303811

2010-12-02

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

#850

20100298239

2010-11-25

Peptide with multiple epitopes

#851

20100297157

2010-11-25

VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION

#852

20100291123

2010-11-18

T Cell Receptor CDR3 Sequences and Methods for Detection

#853

20100291109

2010-11-18

TLR AGONIST (FLAGELLIN)/CD40 AGONIST/ANTIGEN PROTEIN AND DNA CONJUGATES AND USE THEREOF FOR INDUCING SYNERGISTIC ENHANCEMENT IN IMMUNITY

#854

20100287637

2010-11-11

METHODS OF BLOCKING TISSUE DESTRUCTION BY AUTOREACTIVE T CELLS

#855

20100286054

2010-11-11

Myelin basic protein peptide composition

#856

20100278729

2010-11-04

Breast cancer eradication program

#857

20100267622

2010-10-21

Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease

#858

20100260816

2010-10-14

INDUCTION OF IMMUNOLOGICAL TOLERANCE

#859

20100260805

2010-10-14

Peptide for vaccine

#860

20100239548

2010-09-23

Isolation and Identification of T Cells

#861

20100233119

2010-09-16

Suppression of immune response to factor VIII in hemophilia A patients

#862

20100221272

2010-09-02

Immunomodulatory compositions and methods for treating disease with modified host defense peptides

#863

20100221219

2010-09-02

Compositions for treating multiple sclerosis

#864

20100215624

2010-08-26

Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell

#865

20100203008

2010-08-12

NOVEL COMPOSITIONS FOR THE TREATMENT OF VERIOUS INFLAMMATORY CONDITIONS

#866

20100183546

2010-07-22

Method for Increasing CD8+ Cytotoxic T Cell Responses and for Treating Multiple Sclerosis

#867

20100172920

2010-07-08

Method of inducing immune tolerance to type I diabetes

#868

20100166756

2010-07-01

Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID

#869

20100160415

2010-06-24

COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISEASE

#870

20100151000

2010-06-17

Compositions and methods for modulating immune responses

#871

20100143401

2010-06-10

VACCINE PREVENTING AND/OR TREATING AUTOIMMUNE DISEASES

#872

20100135974

2010-06-03

REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE

#873

20100129385

2010-05-27

IMMUNOGENIC MOLECULES

#874

20100119530

2010-05-13

Regulation of TLR Signaling by Complement

#875

20100113361

2010-05-06

Anti-IgE vaccines

#876

20100111995

2010-05-06

Antigen conjugates and uses thereof

#877

20100111982

2010-05-06

Rheumatoid arthritis T cell vaccine

#878

20100107264

2010-04-29

Development of influenza A antivirals

#879

20100104601

2010-04-29

TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENTS USING GENETICALLY MODIFIED LACTOBACILLUS

#880

20100086562

2010-04-08

Use of platelet glycopeptide IIIa epitopes in the treatment of immune thrombocytopenic purpura

#881

20100080816

2010-04-01

Tolerogenic populations of dendritic cells

#882

20100068177

2010-03-18

Methods of organ regeneration using Hox11-expressing pluripotent cells

#883

20100062011

2010-03-11

Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody

#884

20100055070

2010-03-04

Cytokine-based fusion proteins for treatment of multiple sclerosis

#885

20100048679

2010-02-25

POLYNUCLEOTIDE THERAPY

#886

20100047333

2010-02-25

Modified Peptides and Their Use for the Treatment of Autoimmune Diseases

#887

20100047288

2010-02-25

Hybrid cells for treating cancer patients

#888

20100047265

2010-02-25

Active antiangiogenic therapy

#889

20100028320

2010-02-04

Methods and compositions for inhibiting diseases of the central nervous system

#890

20100021486

2010-01-28

TSLP VACCINE FOR THE TREATMENT OF TH2 MEDIATED INFLAMMATORY CONDITIONS

#891

20100021485

2010-01-28

Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases

#892

20100003272

2010-01-07

Method for expanding monocytes

#893

20100003228

2010-01-07

T-CELL VACCINE

#894

20100003225

2010-01-07

HSP60, HSP60 peptides and T cell vaccines for immunomodulation

#895

20090311229

2009-12-17

Isolation and identification of cross-reactive T cells

#896

20090304726

2009-12-10

VIRAL DISPLAY VEHICLES FOR TREATING MULTIPLE SCLEROSIS

#897

20090281170

2009-11-12

POLYNUCLEOTIDE THERAPY

#898

20090280135

2009-11-12

Recombinant MHC molecules useful for manipulation of antigen-specific T-cells

#899

20090280109

2009-11-12

ILT3 and ILT4-related compositions and methods

#900

20090264515

2009-10-22

POLYNUCLEOTIDE THERAPY